Lipid composition heatmap for Study ST004441

Select 2 experimental conditions (at least one from A and at least one from B) to compare lipid profiles.
Group ACombined factors (this analysis)Group B
Treatment:100 nM HHT | Timepoint:24h | Sample source:MDS-L Cells | Injection order:12
Treatment:100 nM HHT | Timepoint:24h | Sample source:MDS-L Cells | Injection order:19
Treatment:100 nM HHT | Timepoint:24h | Sample source:MDS-L Cells | Injection order:24
Treatment:100 nM HHT | Timepoint:24h | Sample source:MDS-L Cells | Injection order:4
Treatment:100 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:21
Treatment:100 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:31
Treatment:100 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:32
Treatment:100 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:6
Treatment:1 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:13
Treatment:1 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:16
Treatment:1 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:17
Treatment:1 nM OT82 | Timepoint:24h | Sample source:MDS-L Cells | Injection order:3
Treatment:Untreated | Timepoint:24h | Sample source:MDS-L Cells | Injection order:10
Treatment:Untreated | Timepoint:24h | Sample source:MDS-L Cells | Injection order:18
Treatment:Untreated | Timepoint:24h | Sample source:MDS-L Cells | Injection order:22
Treatment:Untreated | Timepoint:24h | Sample source:MDS-L Cells | Injection order:7
Use log scale for A and B heatmaps(enhance less abundant metabolites):
Select a lipid RefMet sub class:    

Lipid sub classes in this studyNumber in study
Acyl carnitines15
Saturated FA10
Unsaturated FA9
  logo